Education on smoking alternatives justified but not top priority, says US FDA

Educating consumers about reduced-risk alternatives to smoking is worthwhile – but encouraging them to use smoking-cessation methods that are “scientifically shown to be safe and effective” should still take priority, according to the senior tobacco control official at the US Food and Drug Administration (FDA).

In a commentary published in the scientific journal Addiction, Brian King – director of the FDA’s Center for Tobacco Products (CTP) – discussed opportunities for educating smokers about the risks of tobacco products.

Read full article
I'm already a subscriber

Antonia Di Lorenzo

Assistant news editor/senior reporter
Antonia is a member of the editorial team and holds a masters degree in Law from the University of Naples Federico II, Italy. She moved in 2013 to London, where she completed a postgraduate course at the London School of Journalism. In the UK, she worked as a news reporter for a financial newswire and a magazine before moving to Barcelona in 2019.

Our Key Benefits

The global novel nicotine market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

TobaccoIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organisation